Journalartikel

Administration of keratinocyte growth factor down-regulates the pulmonary capacity of acetylcholine production


AutorenlisteGrau, Veronika; Wilker, Sigrid; Lips, Katrin S.; Hartmann, Petra; Rose, Frank; Padberg, Winfried; Fehrenbach, Heinz; Wessler, Ignatz; Kummer, Wolfgang

Jahr der Veröffentlichung2007

Seiten1955-1963

ZeitschriftThe International Journal of Biochemistry and Cell Biology

Bandnummer39

Heftnummer10

ISSN1357-2725

eISSN1878-5875

DOI Linkhttps://doi.org/10.1016/j.biocel.2007.05.017

VerlagElsevier


Abstract
Keratinocyte growth factor protects the lung against various injurious stimuli. The protective mechanisms, however, are not yet fully understood. The aim of this study is to determine the influence of keratinocyte growth factor on the pulmonary capacity to synthesize acetylcholine, a potent regulator of pulmonary functions which is potentially involved in lung damage. Rats were treated twice (days I and 2) intratracheally with keratinocyte growth factor and analyzed at day 4. The mRNA expression of choline acetyltransferase - the acetylcholine synthesizing enzyme - was analyzed by real-time RT-PCR in the lung and in isolated alveolar epithelial type II cells. Choline acetyltransferase protein was assessed by immunoblotting and immunohistochemistry. Finally, pulmonary acetylcholine content was assessed biochemically. Keratinocyte growth factor-treatment led to decreased levels of choline acetyltransferase mRNA in the lung and in isolated alveolar epithelial type II cells. Accordingly, pulmonary choline acetyltransferase protein levels were reduced and pulmonary acetylcholine content declined from 2.8 nmol (control) to 0.4 nmol acetylcholine per gram of wet weight. In conclusion, the present data show that the potent regulator of pulmonary functions, acetylcholine, is produced by the major pulmonary target cell of keratinocyte growth factor, that is alveolar epithelial type II cells. Acetylcholine synthesis is down-regulated by keratinocyte growth factor administration which might contribute to lung protection and to harmonize surfactant homeostasis under conditions of keratinocyte growth factor-induced alveolar epithelial type II cell hyperplasia. (c) 2007 Elsevier Ltd. All rights reserved.



Zitierstile

Harvard-ZitierstilGrau, V., Wilker, S., Lips, K., Hartmann, P., Rose, F., Padberg, W., et al. (2007) Administration of keratinocyte growth factor down-regulates the pulmonary capacity of acetylcholine production, The International Journal of Biochemistry and Cell Biology, 39(10), pp. 1955-1963. https://doi.org/10.1016/j.biocel.2007.05.017

APA-ZitierstilGrau, V., Wilker, S., Lips, K., Hartmann, P., Rose, F., Padberg, W., Fehrenbach, H., Wessler, I., & Kummer, W. (2007). Administration of keratinocyte growth factor down-regulates the pulmonary capacity of acetylcholine production. The International Journal of Biochemistry and Cell Biology. 39(10), 1955-1963. https://doi.org/10.1016/j.biocel.2007.05.017



Schlagwörter


AFFINITY CHOLINE TRANSPORTERALVEOLARcholine acetyltransferasehigh-affinity choline transporterHYPERPLASIAII EPITHELIAL-CELLSkeratinocyte growth factorKGFNon-neuronal acetylcholineTrachea


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-18-06 um 13:48